Curia Expands Albuquerque Facility for Sterile Drug Manufacturing
Albuquerque, New Mexico, September 3, 2026 Curia Global, Inc., a global contract research, development and manufacturing organization, has announced...
BARDA
Advertisement
Shionogi Expands Fetroja Role in U.S. Drug-Resistance Preparedness
Osaka, Japan – August 28, 2026 Shionogi & Co., Ltd. announced that the Biomedical Advanced Research and Development Authority...
Vedanta Biosciences Secures $60M to Advance Phase 3 VE303
CAMBRIDGE, Mass., August 6, 2026 Vedanta Biosciences announced it has secured $60 million in funding to accelerate development of...
Valion Bio Expands Entolimod Platform for Oncology Growth
SAN ANTONIO, Texas, July 14, 2026 Valion Bio, Inc. has announced major strategic progress across its Entolimod platform, advancing...
Vaxart Reports Positive 12-Month Phase 2b Safety Data
SOUTH SAN FRANCISCO, Calif., July 6, 2026 Vaxart, Inc. has announced positive topline 12-month safety results from the approximately...
Advertisements
Basilea Lands New BARDA Funding for Resistant UTI Antibiotic
ALLSCHWIL, Switzerland — May 28, 2026 Basilea Pharmaceutica announced that the U.S. Biomedical Advanced Research and Development Authority (BARDA),...
RIVANNA Gains FDA Clearance for Accuro XV AI System
CHARLOTTESVILLE, Va., May 7, 2026 RIVANNA announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance...
Advertisement
